Agios Pharmaceuticals
AGIO
AGIO
156 hedge funds and large institutions have $2.39B invested in Agios Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
-5
Holders Change %
-3.11%
% of All Funds
3.89%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.17%
New
26
Increased
59
Reduced
45
Closed
25
Calls
$14.3M
Puts
$17.9M
Net Calls
-$3.57M
Net Calls Change
-$29.5M
Top Buyers
| 1 |
BlackRock
New York
|
$127M |
| 2 |
Goldman Sachs
New York
|
$37.9M |
| 3 |
Norges Bank
Oslo,
Norway
|
$36.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
$18.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
$50.8M |
Top Sellers
| 1 |
Millennium Management
New York
|
$2.19M |
| 2 |
CCI
Columbus Circle Investors
|
$2.5M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
$687K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$252K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
$3.65M |
